Triamcinolone Acetonide Injection, Suspension
Product Images NDC 25021-054

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triamcinolone Acetonide (NDC 25021-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tri0u 0000 01)

Chemical structure of triamcinolone acetonide, a corticosteroid. The diagram shows the molecular framework and functional groups with a molecular weight of 434.50.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Tri0u 0000 02)

Label for Triamcinolone Acetonide Injectable Suspension, USP 40 mg/mL, a 1 mL single-dose vial by Sagent Pharmaceuticals. Intended for intramuscular or intra-articular use only, with contraindications for intravenous, intradermal, intraocular, epidural, or intrathecal administration. Label includes NDC 25021-054, storage instructions, lot, and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.